Parkman Healthcare Partners’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-102,256
| Closed | -$153K | – | 108 |
|
|
2023
Q4 | $153K | Sell |
102,256
-460,250
| -82% | -$690K | 0.02% | 87 |
|
|
2023
Q3 | $827K | Buy |
562,506
+22,753
| +4% | +$33.4K | 0.15% | 93 |
|
|
2023
Q2 | $1.35M | Buy |
539,753
+79,983
| +17% | +$201K | 0.23% | 84 |
|
|
2023
Q1 | $685K | Hold |
459,770
| – | – | 0.15% | 76 |
|
|
2022
Q4 | $644K | Sell |
459,770
-197,873
| -30% | -$277K | 0.17% | 76 |
|
|
2022
Q3 | $2.08M | Buy |
657,643
+7,615
| +1% | +$24.1K | 0.59% | 54 |
|
|
2022
Q2 | $2.26M | Sell |
650,028
-439,223
| -40% | -$1.52M | 0.83% | 41 |
|
|
2022
Q1 | $12.3M | Buy |
1,089,251
+115,068
| +12% | +$1.3M | 3.6% | 5 |
|
|
2021
Q4 | $9.32M | Buy |
974,183
+50,096
| +5% | +$479K | 2.06% | 18 |
|
|
2021
Q3 | $8.18M | Buy |
924,087
+510,000
| +123% | +$4.51M | 2.07% | 18 |
|
|
2021
Q2 | $5.08M | Buy |
414,087
+12,869
| +3% | +$158K | 1.11% | 35 |
|
|
2021
Q1 | $6.4M | Buy |
401,218
+34,527
| +9% | +$550K | 1.48% | 22 |
|
|
2020
Q4 | $5.61M | Sell |
366,691
-33,332
| -8% | -$510K | 1.44% | 27 |
|
|
2020
Q3 | $7.43M | Buy |
400,023
+260,023
| +186% | +$4.83M | 1.97% | 18 |
|
|
2020
Q2 | $1.7M | Buy |
+140,000
| New | +$1.7M | 0.48% | 59 |
|